SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-18-000537
Filing Date
2018-01-16
Accepted
2018-01-16 14:57:28
Documents
60
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2017_americanbrivision.htm 10-K 1052983
2 CERTIFICATION f10k2017ex31-1_american.htm EX-31.1 17159
3 CERTIFICATION f10k2017ex31-2_american.htm EX-31.2 15928
4 CERTIFICATION f10k2017ex32-1_american.htm EX-32.1 6554
5 CERTIFICATION f10k2017ex32-2_american.htm EX-32.2 6422
6 GRAPHIC img_001.jpg GRAPHIC 4115
7 GRAPHIC img_002.jpg GRAPHIC 7929
  Complete submission text file 0001213900-18-000537.txt   3688261

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE mtoo-20170930.xml EX-101.INS 449718
9 XBRL SCHEMA FILE mtoo-20170930.xsd EX-101.SCH 40824
10 XBRL CALCULATION FILE mtoo-20170930_cal.xml EX-101.CAL 45895
11 XBRL DEFINITION FILE mtoo-20170930_def.xml EX-101.DEF 124172
12 XBRL LABEL FILE mtoo-20170930_lab.xml EX-101.LAB 232337
13 XBRL PRESENTATION FILE mtoo-20170930_pre.xml EX-101.PRE 209357
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-91436 | Film No.: 18528424
SIC: 2834 Pharmaceutical Preparations